Definition
The pharmacokinetics describes the journey of a drug molecule through the body. The journey includes its release from the drug product, its absorption into the body system, for some substances its bio-activation via metabolism, the distribution to its site of action and back into the blood, and its elimination from the body either via transformation into inactive metabolites, which are then excreted, or direct excretion of the active entity. The goal of pharmacokinetics is to describe the time course of the drug concentrations in the organism in order to derive dosing regimens that provide most effective clinical drug actions with least side effects.
Characteristics
NSAIDs are mainly administered orally. Formulations for intravenous, intramuscular, topical, rectal, or intraocular administration are also available for some NSAIDs. The pharmacokinetics of the NSAIDs is best described by the...
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ahuja, N., Singh, A., & Singh, B. (2003). Rofecoxib: An update on physicochemical, pharmaceutical, pharmacodynamic and pharmacokinetic aspects. Journal of Pharmacy and Pharmacology, 55, 859–894.
Alsalameh, S., Burian, M., Mahr, G., et al. (2003). Review Article: The pharmacological properties and clinical use of valdecoxib, a New cyclo-oxygenase-2-selective inhibitor. Alimentary Pharmacology & Therapeutics, 17, 489–501.
Bernareggi, A. (1998). Clinical pharmacokinetics of nimesulide. Clinical Pharmacokinetics, 35, 247–274.
Brocks, D. R., & Jamali, F. (1994). Etodolac clinical pharmacokinetics. Clinical Pharmacokinetics, 26, 259–274.
Brouwers, J. R., & de Smet, P. A. (1994). Pharmacokinetic-pharmacodynamic drug interactions with nonsteroidal anti-inflammatory drugs. Clinical Pharmacokinetics, 27, 462–485.
Davies, N. M., & Skjodt, N. M. (2000). Choosing the right nonsteroidal anti-inflammatory drug for the right patient: A pharmacokinetic approach. Clinical Pharmacokinetics, 38, 377–392.
Davies, N. M., & Watson, M. S. (1997). Clinical pharmacokinetics of sulindac. A dynamic old drug. Clinical Pharmacokinetics, 32, 437–459.
Geisslinger, G., Lotsch, J., Menzel, S., et al. (1994). Stereoselective disposition of flurbiprofen in healthy subjects following administration of the single enantiomers. British Journal of Clinical Pharmacology, 37, 392–394.
Helleberg, L. (1981). Clinical pharmacokinetics of indomethacin. Clinical Pharmacokinetics, 6, 245–258.
Hinz, B., Rau, T., Auge, D., et al. (2003). Aceclofenac spares cyclooxygenase-1 as a result of limited but sustained biotransformation to diclofenac. Clinical Pharmacology and Therapeutics, 74, 222–235.
Kauffman, R. E., Lieh-Lai, M. W., Uy, H. G., et al. (1999). Enantiomer-selective pharmacokinetics and metabolism of ketorolac in children. Clinical Pharmacology and Therapeutics, 65, 382–388.
Mroszczak, E., Combs, D., Chaplin, M., et al. (1996). Chiral kinetics and dynamics of ketorolac. The Journal of Clinical Pharmacology, 36, 521–539.
Needs, C. J., & Brooks, P. M. (1985). Clinical pharmacokinetics of the salicylates. Clinical Pharmacokinetics, 10, 164–177.
Olkkola, K. T., Brunetto, A. V., & Mattila, M. J. (1994). Pharmacokinetics of oxicam nonsteroidal anti-inflammatory agents. Clinical Pharmacokinetics, 26, 107–120.
van der Marel, C. D., Anderson, B. J., Romsing, J., et al. (2004). Diclofenac and metabolite pharmacokinetics in children. Paediatric Anaesthesia, 14, 443–451.
Warner, T. D., & Mitchell, J. A. (2004). Cyclooxygenases: New forms, new inhibitors, and lessons from the clinic. The FASEB Journal, 18, 790–804.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag Berlin Heidelberg
About this entry
Cite this entry
Loetsch, J., Oertel, B. (2013). NSAIDs, Pharmacokinetics. In: Gebhart, G.F., Schmidt, R.F. (eds) Encyclopedia of Pain. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-28753-4_2853
Download citation
DOI: https://doi.org/10.1007/978-3-642-28753-4_2853
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-28752-7
Online ISBN: 978-3-642-28753-4
eBook Packages: Biomedical and Life SciencesReference Module Biomedical and Life Sciences